🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,123

Quick answer

1,123 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8314122

    Using of organic solvents in wet granulation of moxifloxacin

    Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8314088

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8314107

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Tue Nov 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8318951

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8318945

    Metalloprotein inhibitors

    The Regents of the University of California · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8318906

    EMP2 antibodies and their therapeutic uses

    The Regents of the University of California · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8318145

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8318182

    Vault compositions for immunization against Chlamydia genital infection

    The Regents of the University of California · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8318156

    Anti-cocaine compositions and treatment

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8318177

    Viral chemokine-antigen fusion proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8318183

    Plasmodium liver stage antigens

    The United States of America, as represented by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8318722

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8318693

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8318490

    Prelamin A pre peptide as a universal stem cell differentiation signal

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8318666

    Use of leptin to treat metabolic abnormalities associated with lipoatrophy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8318700

    Lung-targeted drugs

    The Regents of the University of California · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8318817

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8318733

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8318746

    Nitrogen-containing five-membered heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8318765

    3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8318154

    Super fast-acting insulin compositions

    HALOZYME, INC. · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8318467

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8318483

    Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

    Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8318727

    Polo-like kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8318939

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8318425

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8323632

    Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8324169

    VEGF-activated ligands

    The Regents of the University of California · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8324242

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8324275

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8323665

    Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin

    The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8323662

    Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

    IMMUNE DESIGN CORP. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8323671

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8323634

    Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8324155

    Quinoxaline-containing compounds as hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8324203

    Azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8324201

    Pyrazinooxazepine derivatives

    Takeda Pharmaceutical Company Limited · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8324178

    Method of treatment using alpha-1-adrenergic agonist compounds

    The Regents of the University of California · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8323906

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8323617

    Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

    ANIKA THERAPEUTICS, INC. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8322588

    Structure containing wound treatment material

    Covidien LP · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8323635

    Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

    GENERAL REGENERATIVES, LTD. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8324200

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    The Board of Regents of the University of Texas System · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8324192

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8324385

    Diacylglycerol acyltransferase inhibitors

    Madrigal Pharmaceuticals, Inc. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8324210

    Pterin analogs

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8324220

    Pyrimidines useful as modulators of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,123 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.